UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 356

Sortiert nach

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

Leukemia, 2015-03, Vol.29 (3), p.567-575

2015

Volltextzugriff (PDF)

Clinical Significance of the Most Common Chromosome Translocations in Adult Acute Myeloid Leukemia

Journal of the National Cancer Institute. Monographs, 2008-07, Vol.2008 (39), p.52-57

2008

Volltextzugriff (PDF)

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)

Leukemia, 2017-01, Vol.31 (1), p.34-39

2017

Volltextzugriff (PDF)

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia

Leukemia, 2017-06, Vol.31 (6), p.1278-1285

2017

Volltextzugriff (PDF)

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia

Leukemia, 2017-10, Vol.31 (10), p.2211-2218

2017

Volltextzugriff (PDF)

Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies

Blood, 2004, Vol.103 (1), p.229-235

2004

Volltextzugriff (PDF)

Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2

Leukemia, 2016-11, Vol.30 (11), p.2254-2258

2016

Volltextzugriff (PDF)

No evidence for microsatellite instability in acute myeloid leukemia

Leukemia, 2017-06, Vol.31 (6), p.1474-1476

2017

Volltextzugriff (PDF)

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia

Leukemia, 2013-10, Vol.27 (10), p.2023-2031

2013

Volltextzugriff (PDF)

Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia

Leukemia, 2013-04, Vol.27 (4), p.871-878

2013

Volltextzugriff (PDF)

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

Blood, 2001-06, Vol.97 (11), p.3574-3580

2001

Volltextzugriff (PDF)

Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)

Leukemia, 2016-07, Vol.30 (7), p.1586-1589

2016

Volltextzugriff (PDF)

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study

Cancer research (Chicago, Ill.), 2001-10, Vol.61 (19), p.7233-7239

2001

Volltextzugriff (PDF)

Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

Blood, 1999-06, Vol.93 (11), p.3983-3993

1999

Volltextzugriff (PDF)

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

Leukemia, 2014-06, Vol.28 (6), p.1252-1258

2014

Volltextzugriff (PDF)

BAALC, The Human Member of a Novel Mammalian Neuroectoderm Gene Lineage, is Implicated in Hematopoiesis and Acute Leukemia

Proceedings of the National Academy of Sciences - PNAS, 2001-11, Vol.98 (24), p.13901-13906

2001

Volltextzugriff (PDF)

Simulation-guided engineering of an air-breathing electric propulsion concept

CEAS space journal, 2022, Vol.14 (4), p.741-747

2022

Volltextzugriff (PDF)

Cytogenetics in acute leukemia

Blood reviews, 2004-06, Vol.18 (2), p.115-136

2004

Volltextzugriff (PDF)

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics

Cancer research (Chicago, Ill.), 1998, Vol.58 (1), p.55-59

1998

Volltextzugriff (PDF)

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

Leukemia, 2012-07, Vol.26 (7), p.1713-1717

2012

Volltextzugriff (PDF)

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

Leukemia, 2011-05, Vol.25 (5), p.800-807

2011

Volltextzugriff (PDF)

PGI59 INCREASED AVAILABILITY OF REIMBURSED INTERFERON-FREE TREATMENTS FOR HCV IN POLAND AND ITS COST

Value in health, 2019-11, Vol.22, p.S627-S627

2019

Volltextzugriff (PDF)

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5705-5717

2005

Volltextzugriff (PDF)

1 – 25 von 356

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(294)
Mit Volltextzugriff
(295)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(213)
Humans
(178)
Life Sciences & Biomedicine
(151)
Female
(118)
Male
(106)
Adult
(98)
Middle Aged
(90)
Aged
(66)
Oncology
(66)
Biological And Medical Sciences
(63)
Medical Sciences
(62)
Hematology
(42)
Physical Sciences
(41)
Adolescent
(40)
Karyotyping
(40)
Hematologic And Hematopoietic Diseases
(35)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(34)
Leukemia, Myeloid, Acute - Genetics
(30)
Prognosis
(30)
Chromosome Aberrations
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

Clinical Significance of the Most Common Chromosome Translocations in Adult Acute Myeloid Leukemia

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia

Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies

Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2

No evidence for microsatellite instability in acute myeloid leukemia

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia

Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study

Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

BAALC, The Human Member of a Novel Mammalian Neuroectoderm Gene Lineage, is Implicated in Hematopoiesis and Acute Leukemia

Simulation-guided engineering of an air-breathing electric propulsion concept

Cytogenetics in acute leukemia

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

PGI59 INCREASED AVAILABILITY OF REIMBURSED INTERFERON-FREE TREATMENTS FOR HCV IN POLAND AND ITS COST

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

Suchergebnisse filtern